Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients

Blood Pressure

Volumn 15, Issue 2, 2006, Pages 107-115

  Cuspidi, Cesare ^a   Meani, Stefano ^a   Valerio, Cristiana ^a   Fusi, Veronica ^a   Sala, Carla ^a   Maisaidi, Meilikemu ^b   Zanchetti, Alberto ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Medical University   (China)

Author keywords

Angiotensin II receptor blockade; Concentric hypertrophy; Hypertension; Left ventricular regression

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; HYDROCHLOROTHIAZIDE; LOSARTAN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG DOSE REGIMEN; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; GEOMETRY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOSARTAN; MALE; MIDDLE AGED; PATIENT SELECTION; RISK FACTORS; TREATMENT OUTCOME;

EID: 33745107235     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050600593052     Document Type: Article

References (42)

1. Koren, M. J. and Devereux, R. B. and Casale, P. N. and Savage, D. D. and Laragh, J. H. (1991) Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Med Intern, 114, pp. 345-352.
2. Mensah, G. A. and Pappas, T. W. and Koren, M. J. and Ulin, R. J. and Laragh, J. H. and Devereux, R. B. (1993) Comparison of classification of hypertension severity by blood pressure level and World Health Organization criteria for prediction of concurrent cardiac abnormalities and subsequent complications in essential hypertension. J Hypertens, 11, pp. 1429-1440.
3. Levy, D. and Garrison, R. J. and Savage, D. D. and Kannel, W. B. and Castelli, W. P. (1990) Prognostic implications of echocardiographically-determined left ventricular mass in the Framingham Study. N Engl J Med, 322, pp. 1561-1566.
4. Bikkina, M. and Levy, D. and Evans, J. C. and Larson, M. G. and Benjamin, E. J. and Wolf, P. A. and (1994) Left ventricular mass and the risk of stroke in an elderly cohort: The Framingham Study. JAMA, 272, pp. 33-36.
5. Liao, Y. and Cooper, R. S. and McGee, D. L. and Mensah, G. A. and Ghali, J. K. (1995) The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA, 273, pp. 1592-1597.
6. Klingbeil, A. U. and Schneider, M. and Martus, P. and Messerli, F. H. and Schmieder, R. E. (2003) A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med, 115, pp. 41-46.
7. Trimarco, B. and De Luca, N. and Ricciardelli, B. and Rosiello, G. and Volpe, M. and Condorelli, G. and (1988) Cardiac function in systemic hypertension before and after reversal of left ventricular hypertrophy. Am J Cardiol, 62, pp. 745-750.
8. Perlini, S. and Muiesan, M. L. and Cuspidi, C. and Sampieri, L. and Trimarco, B. and Aurigemma, G. P. and (2001) Midwall mechanics are improved after regression of hypertensive left ventricular hypertrophy and normalization of chamber geometry. Circulation, 103, pp. 678-683.
9. Magrini, F. and Reggiani, P. and Roberts, N. and Meazza, R. and Ciulla, M. and Zanchetti, A. (1988) Effects of angiotensin blockade on coronary circulation and coronary reserve. Am J Med, 84, pp. 55-60.
10. Koren, M. J. and Ulin, R. J. and Laragh, J. H. and Devereux, R. B. (2002) Reduction of left ventricular mass during treatment of essential hypertension is associated with improved prognosis. Am J Hypertens, 15, pp. 1021-1028.
11. Muiesan, M. L. and Salvetti, M. and Rizzoni, D. and Castellano, M. and Donato, F. and Agabiti-Rosei, E. (1995) Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens, 13, pp. 1091-1105.
12. Verdecchia, P. and Schillaci, G. and Borgioni, C. and Ciucci, A. and Gattobigio, R. and Zampi, I. and (1998) Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation, 97, pp. 48-54.
13. Cipriano, C. and Gosse, P. and Bemurat, L. and Mas, D. and Lemetayer, P. and N'Tela, G. and (2001) Prognostic value of left ventricular mass and its evolution during treatment in the Bordeaux cohort of hypertensive patients. Am J Hypertens, 14, pp. 524-529.
14. Levy, D. and Salomon, M. D. and Agostino, R. B. and Belanger, A. J. and Kannel, W. B. (1994) Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation, 90, pp. 1786-1793.
15. Dahlof, B. and Pennert, K. and Hansson, L. (1992) Reversal of left ventricular hypertrophy in hypertensive patients: A meta-analysis of 109 treatment studies. Am J Hypertens, 5, pp. 95-100.
16. Cruickshank, J. M. and Lewis, J. and Moore, V. and Dodd, C. (1992) Reversibility of left ventricular hypertrophy by different types of antihypertensive therapy. J Hum Hypertens, 6, pp. 85-90.
17. Schmieder, R. E. and Martus, P. and Klingbeil, A. U. (1996) Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA, 275, pp. 1507-1513.
18. Schmieder, R. E. and Schlaich, M. F. and Klingbeil, A. U. and Martus, P. (1998) Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1998). Nephrol Dial Transplant, 13, pp. 564-569.
19. Cuspidi, C. and Meani, S. and Fusi, V. and Valerio, C. and Catini, E. and Sala, C. and (2005) Prevalence and correlates of left atrial enlargement in essential hypertension: Role of ventricular geometry and the metabolic syndrome. J Hypertens, 23, pp. 875-882.
20. WHO/ISH Hypertension Guidelines Committee. (1999) 1999 World Health Organization-International Society of Hypertension. J Hypertens, 17, pp. 151-83.
21. (2003) European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension, Guidelines Committee. J Hypetens, 21, pp. 1011-1053.
22. Devereux, R. B. and Reichek, N. (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation, 55, pp. 613-618.
23. Devereux, R. B. and Alonso, D. R. and Lutas, E. M. and Gottlieb, G. J. and Campo, E. and Sachs, I. and Reickek, N. (1986) Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol, 57, pp. 450-458.
24. de Simone, G. and Devereux, R. B. and Daniels, S. R. and Koren, M. J. and Meyer, R. A. and Laragh, J. H. (1995) Effect of growth on variability of left ventricular mass;assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol, 25, pp. 1056-1062.
25. Ganau, A. and Devereux, RB. and Roman, M. J. and de Simone, G. and Pickering, T. G. and Saba, P. S. and (1992) Patterns of left ventricula hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol, 19, pp. 1550-1558.
26. Aurigemma, G. P. and Devereux, R. B. and Wachtell, K. and Palmieri, V. and Boman, K. and Gerdts and (2003) Left ventricular mass regression in the LIFE Study: Effect of previous antihypertensive treatment. Am J Hypertens, 16, pp. 180-186.
27. Krumholz, H. M. and Larson, M. and Levy, D. (1995) Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol, 25, pp. 879-884.
28. Verdecchia, P. and Schillaci, G. and Borgioni, C. and Ciucci, A. and Gattobigio, R. and Zampi, I. and (1996) Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol, 78, pp. 197-202.
29. Muiesan, M. L. and Salvetti, M. and Monteduro, C. and Bonzi, B. and Paini, A. and Viola, S. and (2004) Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension, 43, pp. 731-738.
30. Malmqvist, K. and Kahan, T. and Edner, M. and Held, C. and Hagg, A. and Lind, L. and (2000) Regression of left ventricular hypertrophy in human hypertension with irbesartan. J Hypertens, 19, pp. 1167-1176.
31. Cuspidi, C. and Muiesan, M. L. and Valagussa, L. and Salvetti and Di Biagio, C. and Agabiti-Rosei, E. and (2002) Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: The Candesartan Assessment in the Treatment of Cardiac Hypertrophy (CATCH) study. J Hypertens, 20, pp. 2293-2300.
32. Devereux, R. B. and Pickering, T. G. (1990) Relationship between ambulatory or exercise blood pressure and left ventricular structure: Prognostic implications. J Hypertens, 8, pp. S25-S34.
33. Mancia, G. and Zanchetti, A. and Agabiti-Rosei, E. and Benemio, G. and De Cesaris, R. and Fogari, R. and (1997) Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation, 95, pp. 1464-1470.
34. Verdecchia, P. and Porcellati, C. and Schillaci, G. and Borgioni, C. and Ciucci, A. and Battistelli, M. and (1994) Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension, 24, pp. 793-801.
35. Cuspidi, C. and Meani, S. and Fusi, V. and Valerio, C. and Catini, E. and Magrini, F. and (2005) Isolated ambulatory hypertension and changes in target organ damage. J Hum Hypertens, 19, pp. 471-477.
36. Devereux, R. B. and Wachtell, K. and Gerdts, E. and Borman, K. and Nieminen, M. S. and Papademetriou, V. and (2004) Prognostic significance of left ventricular mass changes during treatment of hypertension. JAMA, 292, pp. 2350-56.
37. Agabiti-Rosei, E. and Trimarco, B. and Muiesan, M. L. and Reid, J. and Salvetti, A. and Tang, R. and (2005) Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens, 23, pp. 1091-1098.
38. Gerdts, E. and Roman, M. J. and Palmieri, V. and Wachtell, K. and Smith, G. and Nieminen, M. S. and (2004) Impact of age on left ventricular hypertrophy regression during antihypertensive treatment with losartan or atenolol (the LIFE study). J Hum Hypertens, 18, pp. 417-422.
39. Terpstra, W. F. and May, J. F. and Smit, A. J. and de Graeff, P. A. and Havinga, T. K. and van den Veur, E. and (2001) Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: The ELVERA trial. J Hypertens, 19, pp. 303-309.
40. Devereux, R. B. and Palmieri, V. and Sharpe, N. and De Quattro, V. and Bella, J. N. and de Simone, G. and (2001) Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension. The Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PRESERVE) Trial. Circulation, 104, pp. 1248-1254.
41. Gosse, P. and Sheridan, D. J. and Zannad, F. and Dubourg, O. and Gueret, P. and Karpov, Y. and (2000) Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20mg: The LIVE study. J Hypertens, 18, pp. 1465-1475.
42. Roman, M. J. and Alderman, M. H. and Pickering, T. G. and Pini, R. and Keating, J. O. and Sealy, J. E. and Devereux, R. B. (1998) Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reduction in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy. Am J Hypertens, 11, pp. 387-396.